403. Can BioTech Extend Life to 150 Years? Gene Editing, and Investing in the Future of Life Sciences (Risa Stack)

Investor Stories 380: Disruptive Forces (Droesch, Patil, Chase)

Replay - Why Healthcare is Broken and How to Fix it, A Future Path Forward Where Doctors are Architects not Providers, and How the Employer-Sponsored Healthcare System is Designed to Fail Us (Adrian Aoun)

Investor Stories 379: Key Advice (Bhattacharyya, Heitzmann, von Tobel)

463. Lessons from Larry Page, Why Subscriptions Won’t Work in the Era of AI, How Enterprises Will Adopt AI, and the 3 Keys to Building Great Products (Manish Patel)

Investor Stories 377: Best LP Question (Nozad, Joaquin, Heitzmann)

462. The Founder and CEO of G2 on AI’s Impact on Enterprise SaaS, How to Embrace the Climb, and Insights on Managing Through Crisis (Godard Abel)

OMR #460 mit Investor Christian Angermayer

DNA als Plattform der Zukunft

Trevor Martin (Mammoth Biosciences) and Ursheet Parikh (Mayfield) - Building Biotech to Last

Curing disease with CRISPR with Trevor Martin from Mammoth Biosciences

CRISPR/Cas9 mit Myopax

Startup Insider Daily • Tesla-Hack • Insolvenzantragspflicht • Ripple • Basecamp-Exodus • CRISPR • Netflix

E42: China's tech crackdown, CRISPR breakthrough, practical climate change solutions & more

Trailblazing discoveries in Gene Editing Solutions